Why Carlyle’s Boss Isn't Worried About A Private Credit Bubble

Among giant private capital firms, Carlyle is playing catch up. Chief Harvey Schwartz insists there is plenty of growth left ...

Is It Too Late To Consider Carlyle Group (CG) After Strong Recent Share Price Gains?

If you are looking at Carlyle Group and wondering whether the current share price still offers value, you are not alone. This ...
PE Hub

Carlyle’s David Rubenstein sets sights on individual investors

Carlyle’s David Rubeinstein on stage at PEI Group’s 2024 NEXUS event. The private equity industry should work to increase access to the asset class for those with lower incomes, according to Carlyle’s ...
Business Wire

Carlyle, SK Capital Partners and bluebird bio Amend Merger Agreement

SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird”), Carlyle (NASDAQ: CG) (“Carlyle”) and SK Capital Partners, LP (“SK ...
Seeking Alpha

Carlyle and SK Capital Receive All Required Regulatory Approvals to Complete the Acquisition of bluebird bio

SOMERVILLE, Mass.--(BUSINESS WIRE)-- bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird” or “the Company”), Carlyle (NASDAQ: CG) (“Carlyle”), SK Capital ...
Hosted on MSN

Bluebird Bio to Be Acquired by Carlyle Group, SK Capital

Cash-strapped gene-therapy company Bluebird bio agreed to be acquired by private-equity firms Carlyle Group and SK Capital Partners in a deal potentially worth up to $96 million. Bluebird on Friday ...
PE Hub

Carlyle to inject capital into tech consultancy Seidor

Seidor saw a turnover of €894m in the 2023 financial year CETP V will provide equity for the investment Carlyle is a global investment firm that managed $435bn of assets UPDATED. Carlyle Group has ...
Business Wire

Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer

All conditions of the Offer have been satisfied and the parties expect to consummate the acquisition on June 2, 2025 WASHINGTON & NEW YORK--(BUSINESS WIRE)--Carlyle (NASDAQ: CG) (“Carlyle”), SK ...